BioNtech Starts Mass Production of COVID Vaccine

BioNTech is a German biotechnology company based in Mainz. It develops and manufactures active immunotherapies.  The company is famous for its case-specific approaches to the treatment of different diseases.

BioNTech has been the one to develop our COVID-19 mRNA vaccine following highly scientific and ethical standards within less than a year.

BioNTech’s vaccine against the coronavirus disease COVID-19, developed with U.S.-based Pfizer, has been authorized for emergency use in countries including the U.S., Canada, and the U.K., as well as the European Union.

The first vaccines are under development at the Marburg site. The delivery will start at the beginning of April. However, the first batch will need the approval of the European Medicines Agency. BioNTech acquired the site from Swiss drug company Novartis NVS, 0.19% NOVN, -0.12% last year.

However, the vaccine maker BNTX, -0.19%, has recently started mass-production at a new Germany site.  This is a tactical move that will help alleviate a shortage of supplies of the shot it has developed with Pfizer PFE, -0.49%.

The factory will produce mRNA, the active ingredient in the shot, which will then be purified and concentrated.

U.S. ordered 100 million dosages of the BioNTech/Pfizer COVID-19 immunization  vaccine

BioNTech SE’s BNTX, – 0.24% stock was down 0.3% and shares of Pfizer Inc. PFE, 0.62% were up 0.1%. The USA is planning to purchase an extra 100 million dosages of its COVID-19 immunization for USD1.95 billion. This brings the absolute number of antibody shares provided in the U.S. by BioNTech and Pfizer to 300 million. Their antibody requires two dosages, implying that the immunization can be spread to 150 million individuals.

The news follows Moderna Inc’s. mRNA, – 1.35% declaration on Thursday that the U.S. had likewise requested an extra 100 million dosages of its two-portion, mRNA-based antibody. In recent months, BioNTech’s stock energized 299.3%, Pfizer shares are down 3.7%, and the more extensive S&P 500 SPX, – 0.02%, is up 16.6%.